Wolfe Research analyst Nigel Coe downgrades W.W. Grainger (NYSE:GWW) from Outperform to Peer Perform.
Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today?
Edesa Biotech Inc (NASDAQ: EDSA) has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
